Results 11 to 20 of about 67,058 (255)

Myelodysplastic Syndrome With Trisomy 8 and Behçet Disease‐Like Intestinal and Upper Gastrointestinal Involvement [PDF]

Clinical Case Reports
We found an extremely rare case of upper gastrointestinal involvement in trisomy 8‐positive myelodysplastic syndrome. This is the first reported case of trisomy 8‐positive myelodysplastic syndrome with both upper and lower gastrointestinal involvement ...
Yuzo Kawata, Kentaro Tominaga, Yusuke Kaneko, Saori Takashima, Yusuke Tani, Yuichi Kojima, Kazuya Takahashi, Shuji Terai   +7 more
doaj   +2 more sources

The myelodysplastic syndromes. [PDF]

BMJ, 1987
The myelodysplastic syndromes constitute a fascinating model for monoclonal premalignant disorders. Haemopoiesis is 'dysplastic' with inefficient maturation of a slowly expanding or sometimes of a stable population, of blood cell precursors. About one third of the patients evolve into acute leukaemia, the result of either a progressive expansion of the
LAYTON, DM, MUFTI, GJ
openaire   +5 more sources

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study

Cancer Medicine, 2021
Chronic myelomonocytic leukemia (CMML) is a rare disease of elderly people characterized by the presence of sustained peripheral blood monocytosis, overlapping features of myeloproliferation, and myelodysplasia.
Liya Ma, Lingxu Jiang, Wenli Yang, Yingwan Luo, Chen Mei, Xinping Zhou, Gaixiang Xu, Weilai Xu, Li Ye, Yanlin Ren, Chenxi Lu, Peipei Lin, Jie Jin, Hongyan Tong   +13 more
doaj   +1 more source

DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia

Technology in Cancer Research & Treatment, 2023
Objectives: Dual specificity phosphatase 1 (DUSP1) is high-expressed in various cancers and plays an important role in the cellular response to agents that damage DNA.
Huali Sun MD, Yanling Ren MD, Xinping Zhou MD, Qi Chen MS, Yanmei Liu MD, Chumeng Zhu MS, Yanyun Ruan MS, Hongli Ruan MD, Hongyan Tong MD, Shenpeng Ying MD, Peipei Lin MD   +10 more
doaj   +1 more source

Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome

Frontiers in Genetics, 2023
Objective: Osteoarthritis (OA) and Myelodysplastic syndrome (MDS) are diseases caused by the same immune disorder with unclear etiology and many similarities in clinical manifestations; however, the specific mechanisms between osteoarthritis and ...
Peicheng Xin, Ming Li, Jing Dong, Hongbo Zhu, Jie Li   +4 more
doaj   +1 more source

Myelodysplastic syndrome: epidemiology, diagnostics and epigenetic disorders

Медицинский вестник Юга России, 2022
Myelodysplastic syndrome is a group of myeloid neoplasms that arise from the action of damaging factors on hematopoietic stem cells, which are based on somatic mutations, which leads to the formation of clonal hematopoiesis.
P. V. Lipilkin, E. D. Kulaeva, A. N. Zeltser, S. V. Mordanov, Yu. V. Shatokhin   +4 more
doaj   +1 more source

Myelodysplastic Syndromes [PDF]

Acta Haematologica, 2009
The myelodysplastic syndromes (MDS) represent a group of syndromes having in common a defective production of one or more myeloid cell lines. They occur in patients which are more than 50 years old without any sex preponderance. The term MDS is replacing the obsolete and archaic term of’preleukemia’ and/ or ‘oligoblastic leukemia’.
C, Sultan, M, Imbert, H, Jouault, J Y, Scoazec   +3 more
  +7 more sources

Myelodysplastic syndromes [PDF]

Seminars in Diagnostic Pathology, 2011
Myelodysplastic syndromes (MDS) are hematopoietic neoplasms characterized by an ineffective hematopoiesis associated with cytopenia(s), functional abnormalities of bone marrow lineages, morphologic dysplasia, and a progression to acute myeloid leukemia.
Jiehao, Zhou, Attilio, Orazi, Magdalena B, Czader   +2 more
openaire   +4 more sources

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation

Haematologica, 2014
A proportion of patients with aplastic anemia who are treated with immunosuppressive therapy develop clonal hematologic disorders, including post-aplastic anemia myelodysplastic syndrome.
Sung-Yong Kim, Jennifer Le Rademacher, Joseph H. Antin, Paolo Anderlini, Mouhab Ayas, Minoo Battiwalla, Jeanette Carreras, Joanne Kurtzberg, Ryotaro Nakamura, Mary Eapen, H. Joachim Deeg   +10 more
doaj   +1 more source

Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients

Haematologica, 2016
The clinical and histopathological distinctions between inherited versus acquired bone marrow failure and myelodysplastic syndromes are challenging.
Siobán B. Keel, Angela Scott, Marilyn Sanchez-Bonilla, Phoenix A. Ho, Suleyman Gulsuner, Colin C. Pritchard, Janis L. Abkowitz, Mary-Claire King, Tom Walsh, Akiko Shimamura   +9 more
doaj   +1 more source